Proven Endpoints
Proven Endpoints
Ridgeland, Mississippi, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular Disorders | Craniomandibular Disorders, Facial Pain, Headache, Jaw Diseases, Mandibular Diseases, Neurologic Manifestations, Orofacial Pain, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, arthropathy, muscle tissue disorder, musculoskeletal system disorder, temporomandibular joint disorder | Recruiting | Not applicable | 2026-10-08 | NCT07639944 | |
| A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | Acute Migraine | Recruiting | Phase 3 | 2026-08-27 | NCT07674654 | |
| A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Phase 3 | 2026-08-20 | NCT07645924 | |
| A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine | Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Phase 3 | 2026-02-27 | NCT04616326 |